← Eichor
Study identifier: NCT06441812 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

Condition: Eosinophilic Asthma Patients  ·  Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

PhasePhase 2
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

This description comes directly from the study's public registry record.

Talk to the study team

Tianqi Zheng  ·  +0518-81220121  ·  tianqi.zheng.tz6@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (1)

West China Hospital of Sichuan UniversityChengdu, Sichuan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06441812